The Altascientist ISSUE NO. 40 — Analytical Testing: Accurate and Complete Characterization of Your API to Maximize Bioavailability Sep 23, 2024
The Altascientist ISSUE NO. 39 — Considerations for Nonclinical Dermal Studies: Advancing to Phase I Apr 11, 2024
The Altascientist ISSUE NO. 38 — Achieving Optimal Preclinical Formulation and Drug Product Manufacture Mar 26, 2024
The Altascientist ISSUE NO. 37 — Quantitative PCR (qPCR) and Droplet Digital (ddPCR): Leading-Edge Analysis for Your Gene Therapy Programs Oct 4, 2023
The Altascientist ISSUE NO. 35 — Critical Considerations for the Safe and Compliant Manufacture of Highly Potent Drugs Aug 24, 2023
